SCHEMBL19448262

SCHEMBL19448262

CCOC(=O)CN1CCNC[C@@H]1COC

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.34
LMNA P02545 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GSK3A P49840 1/20 0.33
GSK3B P49841 1/20 0.33
PKM P14618 1/20 0.32
KMT2A Q03164 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MBTPS1 Q14703 1/20 0.32
POLB P06746 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19448263 1.00 MAPT (0.34) MAPTLMNAALDH1A1HTTABL1
SCHEMBL17549275 0.86 TSHR (0.35) MAPTLMNAALDH1A1CYP2D6SLC6A2
SCHEMBL19448261 0.86 TSHR (0.35) MAPTLMNAALDH1A1CYP2D6SLC6A2
Hydrochloric Acid SCHEMBL19133670 0.85 TSHR (0.34) MAPTLMNAALDH1A1CYP2D6SLC6A2
SCHEMBL18942172 0.78 PARP1 (0.36) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL4441780 0.78 ABL1 (0.35) LMNAABL1RIN1TDP1SMN1; SMN2
SCHEMBL19718789 0.77 HDAC8 (0.41) LMNAALDH1A1CYP2D6KMT2AKDM4E
SCHEMBL31535301 0.77 CYP2D6 (0.39) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL30663182 0.75 CYP1A2 (0.34) MAPTLMNAALDH1A1HTTABL1
SCHEMBL30663148 0.75 CYP1A2 (0.34) MAPTLMNAALDH1A1HTTABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844549-B2 2-aminothiazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2017-12-19 US disclosed
US-9844549-B2 2-aminothiazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2017-12-19 US disclosed
US-20170290824-A1 2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2017-10-12 US disclosed
US-20170290824-A1 2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2017-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170290824-A1 2-AMINOTHIAZOLE DERIVATIVE OR SALT THEREOF CHRM3, CHRM2, TRPM2 MAPT 476/4885LMNA 4516/4885ALDH1A1 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.